Virtus ETF Advisers’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-24,180
| Closed | -$160K | – | 477 |
|
|
2022
Q3 | $160K | Buy |
24,180
+175
| +0.7% | +$1.16K | 0.06% | 344 |
|
|
2022
Q2 | $125K | Buy |
24,005
+10,957
| +84% | +$57.1K | 0.05% | 373 |
|
|
2022
Q1 | $90K | Sell |
13,048
-767
| -6% | -$5.29K | 0.04% | 319 |
|
|
2021
Q4 | $172K | Buy |
13,815
+7,523
| +120% | +$93.7K | 0.07% | 273 |
|
|
2021
Q3 | $197K | Sell |
6,292
-330
| -5% | -$10.3K | 0.09% | 273 |
|
|
2021
Q2 | $190K | Buy |
+6,622
| New | +$190K | 0.08% | 370 |
|